SREBP1 promotes invasive phenotypes by upregulating CYR61/CTGF via the Hippo-YAP pathway

in Endocrine-Related Cancer
View More View Less
  • 1 Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan
  • | 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan
  • | 3 Department of Pathology, MacKay Memorial Hospital and Mackay Medical College, Taipei, Taiwan
  • | 4 Department of Biomedical Sciences and Engineering, National Central University, Taoyuan City, Taiwan
  • | 5 Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan
  • | 6 Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

Correspondence should be addressed to S-P Cheng: surg.mmh@gmail.com
Restricted access

Aberrant lipid metabolism provides bioenergetic, biosynthetic, and redox supplies to cancer cells. Previous studies have reported differential lipid profiling in thyroid malignancies. Sterol regulatory element-binding protein 1 (SREBP1), encoded by the SREBF1 gene, is a master regulator of cellular lipid homeostasis. The clinical and functional significance of SREBP1 in thyroid cancer is not well understood. Here, we showed that SREBP1 expression is significantly upregulated in invasive thyroid cancer than in normal thyroid tissue or benign thyroid nodules. High tumoral SREBP1 expression was associated with extrathyroidal extension, advanced disease stage, and shorter disease-specific survival in patients with differentiated thyroid cancer. SREBP1 overexpression significantly increased the oxygen consumption rate, filopodia formation, and migratory and invasive capacities of thyroid cancer cells. Knockdown of SREBF1 or treatment with an SREBP1 activation inhibitor fatostatin had the opposite effect. RNA-Seq analysis showed that modulation of SREBP1 expression was accompanied by corresponding changes in the expression of epithelial–mesenchymal transition markers and CYR61/CTGF. SREBP1-facilitated cell invasion could be abrogated by treatment with a YAP inhibitor such as verteporfin or genetic silencing of CYR61 or CTGF. In summary, SREBP1 upregulation can be used as a prognostic indicator for thyroid cancer and SREBP1 overexpression is involved in cancer invasiveness, at least partly, through upregulation of CYR61/CTGF via the Hippo-YAP pathway.

Supplementary Materials

 

Society for Endocrinology logo

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 781 781 547
Full Text Views 54 54 45
PDF Downloads 84 84 72
  • Cancer Genome Atlas Research Network 2014 Integrated genomic characterization of papillary thyroid carcinoma. Cell 159 676690. (https://doi.org/10.1016/j.cell.2014.09.050)

    • Search Google Scholar
    • Export Citation
  • Chen M, Zhang J, Sampieri K, Clohessy JG, Mendez L, Gonzalez-Billalabeitia E, Liu XS, Lee YR, Fung J & Katon JM et al.2018 An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nature Genetics 50 206218. (https://doi.org/10.1038/s41588-017-0027-2)

    • Search Google Scholar
    • Export Citation
  • Cheng SP, Lee JJ, Chang YC, Lin CH, Li YS & Liu CL 2020 Overexpression of chitinase-3-like protein 1 is associated with structural recurrence in patients with differentiated thyroid cancer. Journal of Pathology 252 114124. (https://doi.org/10.1002/path.5503)

    • Search Google Scholar
    • Export Citation
  • Chin LH, Hsu SP, Zhong WB & Liang YC 2016 Involvement of cysteine-rich protein 61 in the epidermal growth factor-induced migration of human anaplastic thyroid cancer cells. Molecular Carcinogenesis 55 622632. (https://doi.org/10.1002/mc.22308)

    • Search Google Scholar
    • Export Citation
  • DeHoog RJ, Zhang J, Alore E, Lin JQ, Yu W, Woody S, Almendariz C, Lin M, Engelsman AF & Sidhu SB et al.2019 Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies. PNAS 116 2140121408. (https://doi.org/10.1073/pnas.1911333116)

    • Search Google Scholar
    • Export Citation
  • Grosse J, Wehland M, Pietsch J, Schulz H, Saar K, Hubner N, Eilles C, Bauer J, Abou-El-Ardat K & Baatout S et al.2012 Gravity-sensitive signaling drives 3-dimensional formation of multicellular thyroid cancer spheroids. FASEB Journal 26 51245140. (https://doi.org/10.1096/fj.12-215749)

    • Search Google Scholar
    • Export Citation
  • Guo S, Wang Y, Zhou D & Li Z 2014 Significantly increased monounsaturated lipids relative to polyunsaturated lipids in six types of cancer microenvironment are observed by mass spectrometry imaging. Scientific Reports 4 5959. (https://doi.org/10.1038/srep05959)

    • Search Google Scholar
    • Export Citation
  • Haase J, Misiak D, Bauer M, Pazaitis N, Braun J, Potschke R, Mensch A, Bell JL, Dralle H & Siebolts U et al.2021 IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. Modern Pathology 34 3241. (https://doi.org/10.1038/s41379-020-0630-0)

    • Search Google Scholar
    • Export Citation
  • Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646674. (https://doi.org/10.1016/j.cell.2011.02.013)

  • Huang FQ, Li J, Jiang L, Wang FX, Alolga RN, Wang MJ, Min WJ, Ma G, Zhao YJ & Wang SL et al.2019 Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma. International Journal of Cancer 144 868876. (https://doi.org/10.1002/ijc.31925)

    • Search Google Scholar
    • Export Citation
  • Huang B, Shang H, Cao Z, Wei L, Zhao J, Peng J & Lin J 2020a Babao Dan, a traditional Chinese medicine formula, arrests the G1/S phase transition in gastric cancer cells by activating p53 pathway. International Journal of Gerontology 14 7782. (https://doi.org/10.6890/IJGE.202002_14(1.0016)

    • Search Google Scholar
    • Export Citation
  • Huang CM, Huang CS, Hsu TN, Huang MS, Fong IH, Lee WH & Liu SC 2020b Disruption of cancer metabolic SREBP1/miR-142-5p suppresses epithelial-mesenchymal transition and stemness in esophageal carcinoma. Cells 9 7. (https://doi.org/10.3390/cells9010007)

    • Search Google Scholar
    • Export Citation
  • Ibar C & Irvine KD 2020 Integration of Hippo-YAP signaling with metabolism. Developmental Cell 54 256267. (https://doi.org/10.1016/j.devcel.2020.06.025)

    • Search Google Scholar
    • Export Citation
  • Jacquemet G, Paatero I, Carisey AF, Padzik A, Orange JS, Hamidi H & Ivaska J 2017 FiloQuant reveals increased filopodia density during breast cancer progression. Journal of Cell Biology 216 33873403. (https://doi.org/10.1083/jcb.201704045)

    • Search Google Scholar
    • Export Citation
  • Jeon MJ, You MH, Han JM, Sim S, Yoo HJ, Lee WK, Kim TY, Song DE, Shong YK & Kim WG et al.2020 High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer. Thyroid 30 16251638. (https://doi.org/10.1089/thy.2020.0105)

    • Search Google Scholar
    • Export Citation
  • Jin X, Demere Z, Nair K, Ali A, Ferraro GB, Natoli T, Deik A, Petronio L, Tang AA & Zhu C et al.2020 A metastasis map of human cancer cell lines. Nature 588 331336. (https://doi.org/10.1038/s41586-020-2969-2)

    • Search Google Scholar
    • Export Citation
  • Kale VP, Hengst JA, Desai DH, Amin SG & Yun JK 2015 The regulatory roles of ROCK and MRCK kinases in the plasticity of cancer cell migration. Cancer Letters 361 185196. (https://doi.org/10.1016/j.canlet.2015.03.017)

    • Search Google Scholar
    • Export Citation
  • Kamisuki S, Mao Q, Abu-Elheiga L, Gu Z, Kugimiya A, Kwon Y, Shinohara T, Kawazoe Y, Sato S & Asakura K et al.2009 A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chemistry and Biology 16 882892. (https://doi.org/10.1016/j.chembiol.2009.07.007)

    • Search Google Scholar
    • Export Citation
  • Lee SE, Lee JU, Lee MH, Ryu MJ, Kim SJ, Kim YK, Choi MJ, Kim KS, Kim JM & Kim JW et al.2013 RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer. Oncogenesis 2 e55. (https://doi.org/10.1038/oncsis.2013.12)

    • Search Google Scholar
    • Export Citation
  • Lee JJ, Hsu YC, Li YS & Cheng SP 2021 Galectin-3 inhibitors suppress anoikis resistance and invasive capacity in thyroid cancer cells. International Journal of Endocrinology 2021 5583491. (https://doi.org/10.1155/2021/5583491)

    • Search Google Scholar
    • Export Citation
  • Li C, Peng X, Lv J, Zou H, Liu J, Zhang K & Li Z 2020 SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer. Biomedicine and Pharmacotherapy 123 109791. (https://doi.org/10.1016/j.biopha.2019.109791)

    • Search Google Scholar
    • Export Citation
  • Liu CL, Yang PS, Wang TY, Huang SY, Kuo YH & Cheng SP 2019 PGC1α downregulation and glycolytic phenotype in thyroid cancer. Journal of Cancer 10 38193829. (https://doi.org/10.7150/jca.30018)

    • Search Google Scholar
    • Export Citation
  • Liu CL, Hsu YC, Lee JJ, Chen MJ, Lin CH, Huang SY & Cheng SP 2020 Targeting the pentose phosphate pathway increases reactive oxygen species and induces apoptosis in thyroid cancer cells. Molecular and Cellular Endocrinology 499 110595. (https://doi.org/10.1016/j.mce.2019.110595)

    • Search Google Scholar
    • Export Citation
  • Liu CL, Cheng SP, Chen MJ, Lin CH, Chen SN, Kuo YH & Chang YC 2021 Quinolinate phosphoribosyltransferase promotes invasiveness of breast cancer through myosin light chain phosphorylation. Frontiers in Endocrinology 11 621944. (https://doi.org/10.3389/fendo.2020.621944)

    • Search Google Scholar
    • Export Citation
  • Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO & Pan D 2012 Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes and Development 26 13001305. (https://doi.org/10.1101/gad.192856.112)

    • Search Google Scholar
    • Export Citation
  • Montesdeoca N, Lopez M, Ariza X, Herrero L & Makowski K 2020 Inhibitors of lipogenic enzymes as a potential therapy against cancer. FASEB Journal 34 1135511381. (https://doi.org/10.1096/fj.202000705R)

    • Search Google Scholar
    • Export Citation
  • Noto A, De Vitis C, Pisanu ME, Roscilli G, Ricci G, Catizone A, Sorrentino G, Chianese G, Taglialatela-Scafati O & Trisciuoglio D et al.2017 Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Oncogene 36 45734584. (https://doi.org/10.1038/onc.2017.75)

    • Search Google Scholar
    • Export Citation
  • Ren H, Liu X, Li F, He X & Zhao N 2021 Identification of a six gene prognosis signature for papillary thyroid cancer using multi-omics methods and bioinformatics analysis. Frontiers in Oncology 11 624421. (https://doi.org/10.3389/fonc.2021.624421)

    • Search Google Scholar
    • Export Citation
  • Revilla G, Pons MP, Baila-Rueda L, Garcia-Leon A, Santos D, Cenarro A, Magalhaes M, Blanco RM, Moral A & Ignacio Perez J et al.2019 Cholesterol and 27-hydroxycholesterol promote thyroid carcinoma aggressiveness. Scientific Reports 9 10260. (https://doi.org/10.1038/s41598-019-46727-2)

    • Search Google Scholar
    • Export Citation
  • Ringseis R, Rauer C, Rothe S, Gessner DK, Schutz LM, Luci S, Wen G & Eder K 2013 Sterol regulatory element-binding proteins are regulators of the NIS gene in thyroid cells. Molecular Endocrinology 27 781800. (https://doi.org/10.1210/me.2012-1269)

    • Search Google Scholar
    • Export Citation
  • Rohrig F & Schulze A 2016 The multifaceted roles of fatty acid synthesis in cancer. Nature Reviews: Cancer 16 732749. (https://doi.org/10.1038/nrc.2016.89)

    • Search Google Scholar
    • Export Citation
  • Samimi H, Atlasi R, Parichehreh-Dizaji S, Khazaei S, Akhavan Rahnama M, Seifirad S & Haghpanah V 2021 A systematic review on thyroid organoid models: time-trend and its achievements. American Journal of Physiology: Endocrinology and Metabolism 320 E581E590. (https://doi.org/10.1152/ajpendo.00479.2020)

    • Search Google Scholar
    • Export Citation
  • Shimano H & Sato R 2017 SREBP-regulated lipid metabolism: convergent physiology – divergent pathophysiology. Nature Reviews: Endocrinology 13 710730. (https://doi.org/10.1038/nrendo.2017.91)

    • Search Google Scholar
    • Export Citation
  • Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R & Piazza S et al.2014 Metabolic control of YAP and TAZ by the mevalonate pathway. Nature Cell Biology 16 357366. (https://doi.org/10.1038/ncb2936)

    • Search Google Scholar
    • Export Citation
  • Tian Y, Nie X, Xu S, Li Y, Huang T, Tang H & Wang Y 2015 Integrative metabonomics as potential method for diagnosis of thyroid malignancy. Scientific Reports 5 14869. (https://doi.org/10.1038/srep14869)

    • Search Google Scholar
    • Export Citation
  • Tomas G, Tarabichi M, Gacquer D, Hebrant A, Dom G, Dumont JE, Keutgen X, Fahey 3rd TJ, Maenhaut C & Detours V 2012 A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnostic. Oncogene 31 44904498. (https://doi.org/10.1038/onc.2011.626)

    • Search Google Scholar
    • Export Citation
  • Tsai CC, Chien MN, Chang YC, Lee JJ, Dai SH & Cheng SP 2019 Overexpression of histone H3 lysine 27 trimethylation is associated with aggressiveness and dedifferentiation of thyroid cancer. Endocrine Pathology 30 305311. (https://doi.org/10.1007/s12022-019-09586-1)

    • Search Google Scholar
    • Export Citation
  • Uddin S, Siraj AK, Al-Rasheed M, Ahmed M, Bu R, Myers JN, Al-Nuaim A, Al-Sobhi S, Al-Dayel F & Bavi P et al.2008 Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism 93 40884097. (https://doi.org/10.1210/jc.2008-0503)

    • Search Google Scholar
    • Export Citation
  • Ugolini C, Borrelli N, Niccoli C, Elisei R, Viola D, Vitti P, Miccoli P & Basolo F 2017 Role of YAP-1 in thyroid tumor progression and outcome. Applied Immunohistochemistry and Molecular Morphology 25 581585. (https://doi.org/10.1097/PAI.0000000000000344)

    • Search Google Scholar
    • Export Citation
  • Uhlen M, Zhang C, Lee S, Sjostedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z & Edfors F et al.2017 A pathology atlas of the human cancer transcriptome. Science 357 eaan2507. (https://doi.org/10.1126/science.aan2507)

    • Search Google Scholar
    • Export Citation
  • Valerio L, Guidoccio F, Giani C, Tardelli E, Puccini G, Puleo L, Minaldi E, Boni G, Elisei R & Volterrani D 2021 [18F]-FDG-PET/CT correlates with the response of radiorefractory thyroid cancer to lenvatinib and patient survival. Journal of Clinical Endocrinology and Metabolism 106 23552366. (https://doi.org/10.1210/clinem/dgab278)

    • Search Google Scholar
    • Export Citation
  • von Roemeling CA, Marlow LA, Pinkerton AB, Crist A, Miller J, Tun HW, Smallridge RC & Copland JA 2015 Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. Journal of Clinical Endocrinology and Metabolism 100 E697E709. (https://doi.org/10.1210/jc.2014-2764)

    • Search Google Scholar
    • Export Citation
  • Wang TY, Liu CL, Chen MJ, Lee JJ, Pun PC & Cheng SP 2015 Expression of haem oxygenase-1 correlates with tumour aggressiveness and BRAF V600E expression in thyroid cancer. Histopathology 66 447456. (https://doi.org/10.1111/his.12562)

    • Search Google Scholar
    • Export Citation
  • Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D & Bhavana VH et al.2018 Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Reports 25 1304 .e51317 .e 5. (https://doi.org/10.1016/j.celrep.2018.10.001)

    • Search Google Scholar
    • Export Citation
  • Wen G, Eder K & Ringseis R 2016 Sterol regulatory element-binding proteins are transcriptional regulators of the thyroglobulin gene in thyroid cells. Biochimica et Biophysica Acta 1859 9941003. (https://doi.org/10.1016/j.bbagrm.2016.06.004)

    • Search Google Scholar
    • Export Citation
  • Wojakowska A, Chekan M, Marczak Ł, Polanski K, Lange D, Pietrowska M & Widlak P 2015 Detection of metabolites discriminating subtypes of thyroid cancer: molecular profiling of FFPE samples using the GC/MS approach. Molecular and Cellular Endocrinology 417 149157. (https://doi.org/10.1016/j.mce.2015.09.021)

    • Search Google Scholar
    • Export Citation
  • Yang PS, Hsu YC, Lee JJ, Chen MJ, Huang SY & Cheng SP 2018 Heme oxygenase-1 inhibitors induce cell cycle arrest and suppress tumor growth in thyroid cancer cells. International Journal of Molecular Sciences 19 2502. (https://doi.org/10.3390/ijms19092502)

    • Search Google Scholar
    • Export Citation